QCG
FATE icon

Quadrant Capital Group’s Fate Therapeutics FATE Stock Holding History

Quadrant Capital Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-349
Closed -$1.22K – 2756
2024
Q3 		$1.22K Buy
349
+81
+30% +$315 ﹤0.01% 2564
2024
Q2 		$880 Sell
268
-172
-39% -$753 ﹤0.01% 2576
2024
Q1 		$3.23K Buy
+440
New +$2.72K ﹤0.01% 2410
2023
Q3 		– Sell
-417
Closed -$1.99K – 2713
2023
Q2 		$1.99K Sell
417
-3,278
-89% -$18.1K ﹤0.01% 2417
2023
Q1 		$21.1K Buy
3,695
+2,956
+400% +$17.8K ﹤0.01% 1677
2022
Q4 		$7.46K Buy
739
+722
+4,247% +$13.6K ﹤0.01% 2084
2022
Q3 		$0 Sell
17
-17
-50% -$491 ﹤0.01% 2690
2022
Q2 		$1K Sell
34
-196
-85% -$5.41K ﹤0.01% 2359
2022
Q1 		$9K Buy
230
+190
+475% +$7.36K ﹤0.01% 1690
2021
Q4 		$2K Buy
40
+33
+471% +$1.87K ﹤0.01% 2124
2021
Q3 		$0 Buy
7
+1
+17% +$78 ﹤0.01% 2539
2021
Q2 		$1K Sell
6
-2
-25% -$161 ﹤0.01% 2254
2021
Q1 		$1K Buy
+8
New +$767 ﹤0.01% 2209

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return